CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 96 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $44,000 | +18.9% | 4,287 | +15.9% | 0.00% | – |
| Q3 2016 | $37,000 | -5.1% | 3,699 | +7.3% | 0.00% | – |
| Q2 2016 | $39,000 | -18.8% | 3,447 | -2.4% | 0.00% | – |
| Q1 2016 | $48,000 | -86.2% | 3,531 | -80.8% | 0.00% | – |
| Q4 2015 | $348,000 | +40.9% | 18,381 | +39.7% | 0.00% | – |
| Q3 2015 | $247,000 | -30.0% | 13,156 | -43.5% | 0.00% | – |
| Q1 2015 | $353,000 | -39.1% | 23,299 | -46.5% | 0.00% | – |
| Q4 2014 | $580,000 | -37.4% | 43,568 | -40.7% | 0.00% | -100.0% |
| Q3 2014 | $926,000 | -49.6% | 73,455 | -59.6% | 0.00% | 0.0% |
| Q2 2014 | $1,838,000 | +66.2% | 181,971 | +121.4% | 0.00% | 0.0% |
| Q1 2014 | $1,106,000 | – | 82,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
| Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
| ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
| INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
| Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
| Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
| RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
| Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
| Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |